Quality AI will help healthcare providers save more lives through better, faster screening and detection. Aival bridges the gap between clinicians and AI vendors, to allow an AI system to be properly analysed and monitored, and give users the confidence they need to know it will work at their local site and for their patients.
We aim to accelerate the adoption of robust and safe AI, by enabling players across the ecosystem to thoroughly assess AI products before and after deployment
**NEW**: See how we help Imaging Networks with the AI Diagnostics Fund
Clinicians and decision-makers looking to adopt AI, helping them validate performance claims on local data, ensure fairness across demographics, and rapidly compare different AI products
PACS vendors and other platforms offering suites of AI products, helping healthcare decision-making clients to assess products across the platform and monitor performance after deployment
Developers of imaging AI products looking to sell to healthcare providers, helping them gain trust with clinical buyers to accelerate sales, and to monitor deployed products for post-market surveillance
Fast, and can be used without technical training
Vendor-neutral external assessment and monitoring
Scalable with standardised outputs that can be viewed across products
